Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pleural Malignant Mesothelioma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT05660616
What this trial is testing

Switch-Maintenance Gemcitabine After First-Line Chemotherapy In Patients With Malignant Pleural Mesothelioma

Who this might be right for
Malignant Pleural Mesothelioma
Ain Shams University 40
Early research (Phase 1)Looking for participantsNCT07192900
What this trial is testing

Fast TILs to Treat Metastatic Cancer Patients With Pleural Disease

Who this might be right for
Malignant Pleural EffusionMalignant MesotheliomaPleural Effusion, Malignant+1 more
David Bartlett, MD 10
Early research (Phase 1)UnknownNCT02580747
What this trial is testing

Treatment of Relapsed and/or Chemotherapy Refractory Advanced Malignancies by CART-meso

Who this might be right for
Malignant MesotheliomaPancreatic CancerOvarian Tumor+3 more
Chinese PLA General Hospital 20
Early research (Phase 1)Study completedNCT01355965
What this trial is testing

Autologous Redirected RNA Meso-CIR T Cells

Who this might be right for
Malignant Pleural Mesothelioma
University of Pennsylvania 18
Not applicableLooking for participantsNCT07403630
What this trial is testing

INTEGRATIVE "MULTI-OMICS" AND FUNCTIONAL PLATFORM FOR THE COMPLETE DIAGNOSTIC CHARACTERIZATION OF TUMORS: THE ITALIAN TUMOR CHEMOGENOMIC PROFILER (IT-TCP)

Who this might be right for
Acute LeukemiaMultiple MyelomaSquamous Cell Carcinoma+9 more
Azienda Ospedaliero-Universitaria di Parma 300
Testing effectiveness (Phase 2)Looking for participantsNCT05765084
What this trial is testing

Integration of the PD-L1 Inhibitor Atezolizumab and WT1/DC Vaccination Into Platinum/Pemetrexed-based First-line Treatment for Epithelioid Malignant Pleural Mesothelioma

Who this might be right for
Malignant Pleural Mesothelioma
University Hospital, Antwerp 15
Testing effectiveness (Phase 2)Active Not RecruitingNCT03918252
What this trial is testing

Neoadjuvant Immune Checkpoint Blockade in Resectable Malignant Pleural Mesothelioma

Who this might be right for
Mesothelioma
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 30
Early research (Phase 1)Study completedNCT00003974
What this trial is testing

Vaccine Therapy in Treating Patients With Stage I, Stage II, or Stage IIIA Non-small Cell Lung Cancer or With Stage I or Stage II Mesothelioma

Who this might be right for
Lung CancerMalignant Mesothelioma
Roswell Park Cancer Institute 20
Not applicableStudy completedNCT01126346
What this trial is testing

Quality of Life and Survivorship Care in Patients Undergoing Hyperthermic Intraperitoneal Chemotherapy (HIPEC)

Who this might be right for
Advanced Malignant MesotheliomaCarcinoma of the AppendixOvarian Sarcoma+13 more
Wake Forest University Health Sciences 10
Testing effectiveness (Phase 2)Study completedNCT00272558
What this trial is testing

Study of Carboplatin and Vinorelbine in Malignant Pleural Mesothelioma

Who this might be right for
Malignant Pleural Mesothelioma
Rigshospitalet, Denmark 40
Early research (Phase 1)UnknownNCT06281860
What this trial is testing

Treatment Pleural Carcinosis of Pressurized IntraThoracic Hyperthermic Aerosol Cisplatin Administration

Who this might be right for
Mesothelioma, MalignantCarcinoma, Non-Small-Cell LungCarcinoma Breast Stage IV+3 more
Dr Jean Yannis PERENTES 39
Testing effectiveness (Phase 2)Study completedNCT00062283
What this trial is testing

Alanosine in Treating Patients With Cancer

Who this might be right for
Lung CancerMalignant MesotheliomaPancreatic Cancer+1 more
Memorial Sloan Kettering Cancer Center
Very early researchEnded earlyNCT04213794
What this trial is testing

Heated Intra-peritoneal Chemotherapy With Doxorubicin and Cisplatin for Abdominal for Pelvic Tumors in Pediatric Patients

Who this might be right for
Malignant Abdominal NeoplasmMalignant Pelvic NeoplasmRecurrent Colon Carcinoma+24 more
Mayo Clinic 2
Not applicableEnded earlyNCT03684486
What this trial is testing

Rehabilitation by Effort for Patients With Advanced Bronchial Cancer

Who this might be right for
Bronchial CancerMalignant Mesothelioma
University Hospital, Toulouse 19
Testing effectiveness (Phase 2)Study completedNCT00165516
What this trial is testing

Extrapleural Pneumonectomy With Intraoperative Intrathoracic/Intraperitoneal Heated Cisplatin With Amifostine and Sodium Thiosulfate

Who this might be right for
Pleural MesotheliomaMalignant Pleural Mesothelioma
Dana-Farber Cancer Institute 85
Testing effectiveness (Phase 2)Study completedNCT00004033
What this trial is testing

Liposomal-Cisplatin Analogue (L-NDDP) in Treating Patients With Malignant Pleural Mesothelioma

Who this might be right for
Malignant Mesothelioma
NYU Langone Health 30
Not applicableEnded earlyNCT02648763
What this trial is testing

Staging Procedures to Diagnose Malignant Pleural Mesothelioma

Who this might be right for
MesotheliomaSolitary Fibrous Tumor of the Pleura
Mayo Clinic 33
Testing effectiveness (Phase 2)UnknownNCT00886028
What this trial is testing

Palliative Treatment With Liposomal Doxorubicin Plus Cisplatin for Patients With Malignant Pleural Mesothelioma

Who this might be right for
Malignant Pleural Mesothelioma
National Institute of Cancerología 31
Early research (Phase 1)Study completedNCT00003263
What this trial is testing

Cisplatin, Interferon Alfa, Surgery, and Radiation Therapy in Treating Patients With Malignant Pleural Mesothelioma

Who this might be right for
Malignant Mesothelioma
Fox Chase Cancer Center 6
Not applicableWithdrawnNCT04985357
What this trial is testing

Defining the Clinical Potential of Mass Response As a Biomarker for Patient Tumor Sensitivity to Drugs

Who this might be right for
Stage III Breast CancerStage IV Breast CancerStage III Lung Cancer+35 more
Travera Inc
Next Page